StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.01−0.38 (-1.10%)

Close on Nov 19, 2026Market cap $2.53BP/E –Yield –

Earnings

Xencor's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 24, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q2 FY2026
$51.20M
+17.4% on a year earlier
EPS, Q2 FY2026
-$0.29
-$0.41 a year earlier
Latest guidance
Raised
Aug 5, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Xencor's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 24, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026after the close–––Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026during market hours$51.20M+17.4%-$0.29Release
Q1 FY2026ended Mar 31, 2026May 6, 2026during market hours$4.50M-86.2%–Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026during market hours$28.20M-46.6%-$0.09Release
Q3 FY2025ended Sep 30, 2025Nov 5, 2025during market hours$21.00M+96.3%-$0.08Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025during market hours$43.60M+156.5%-$0.41Release
Q1 FY2025ended Mar 31, 2025May 7, 2025during market hours$32.70M+155.5%-$0.66Release
Q4 FY2024ended Dec 31, 2024Feb 27, 2025before the open$52.80M+18.1%-$0.62Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024during market hours$10.70M-81.9%-$0.71Release
Q2 FY2024ended Jun 30, 2024Aug 5, 2024during market hours$17.00M-62.6%-$1.07Release
Q1 FY2024ended Mar 31, 2024May 9, 2024during market hours$12.80M-32.6%-$1.11Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Xencor's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
cash, cash equivalents and marketable debt securitiesFY2026$420.00M – $440.00M$400.00M – $430.00MRaisedAug 5, 2026
cash, cash equivalents and marketable debt securitiesFY2026$380.00M – $400.00M–NewMay 6, 2026

Guidance history

Every forecast Xencor put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 5, 2026cash, cash equivalents and marketable debt securitiesFY2026$420.00M – $440.00MRaised
May 6, 2026cash, cash equivalents and marketable debt securitiesFY2026$380.00M – $400.00MNew
Feb 25, 2026cash, cash equivalents and marketable debt securitiesFY2026$400.00M – $430.00MNew
Nov 5, 2025cash, cash equivalents and marketable debt securitiesFY2025$570.00M – $590.00MNew
Aug 6, 2025cash, cash equivalents and marketable debt securitiesFY2025$555.00M – $585.00MRaised
May 7, 2025cash, cash equivalents and marketable debt securitiesFY2025$535.00M – $585.00MReaffirmed
Feb 27, 2025cash, cash equivalents and marketable debt securitiesFY2025$535.00M – $585.00MNew
Nov 6, 2024cash, cash equivalents and marketable debt securitiesFY2024$690.00M – $710.00MRaised
Aug 5, 2024cash, cash equivalents and marketable debt securitiesFY2024$475.00M – $525.00MReaffirmed
May 9, 2024cash, cash equivalents and marketable debt securitiesFY2024$475.00M – $525.00MReaffirmed
Feb 27, 2024cash, cash equivalents and marketable debt securitiesFY2024$475.00M – $525.00MNew
Nov 7, 2023cash, cash equivalents and marketable debt securitiesFY2023$615.00M – $665.00MRaised
Aug 3, 2023cash, cash equivalents, receivables and marketable debt securitiesFY2023$425.00M – $475.00MReaffirmed
May 8, 2023cash, cash equivalents, receivables and marketable debt securitiesFY2023$425.00M – $475.00MReaffirmed
Feb 23, 2023cash, cash equivalents, receivables and marketable debt securitiesFY2023$425.00M – $475.00MNew
Nov 7, 2022cash, cash equivalents, receivables and marketable debt securitiesFY2022$575.00M – $600.00MRaised
Aug 3, 2022cash, cash equivalents, receivables and marketable debt securitiesFY2022$550.00M – $575.00MRaised
May 5, 2022cash, cash equivalents, receivables and marketable debt securitiesFY2022$500.00M – $550.00MReaffirmed
Feb 23, 2022cash, cash equivalents, receivables and marketable debt securitiesFY2022$500.00M – $550.00MNew
Nov 8, 2021cash, cash equivalents, receivables and marketable debt securitiesFY2021$575.00M – $625.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Xencor filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. Update
  8. Update
  9. Update
  10. Results
  11. Results
  12. Results
  13. Update
  14. Update
  15. Results

See a number that looks wrong?